Perceptive Advisors as of Dec. 31, 2021
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 145 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Travere Therapeutics Note 2.500% 9/1 (Principal) | 7.5 | $485M | 45M | 10.77 | |
| Mirati Therapeutics | 7.4 | $482M | 3.3M | 146.69 | |
| Lianbio Sponsored Ads (LIANY) | 5.4 | $347M | 56M | 6.16 | |
| Amicus Therapeutics (FOLD) | 4.7 | $307M | 27M | 11.55 | |
| Springworks Therapeutics (SWTX) | 4.6 | $301M | 4.8M | 61.98 | |
| Iovance Biotherapeutics (IOVA) | 3.0 | $193M | 10M | 19.09 | |
| Horizon Therapeutics Pub L SHS | 2.9 | $187M | 1.7M | 107.76 | |
| Collegium Pharmaceutical Note 2.625% 2/1 (Principal) | 2.6 | $169M | 18M | 9.68 | |
| Meiragtx Holdings (MGTX) | 2.5 | $165M | 6.9M | 23.74 | |
| Cerevel Therapeutics Hldng I (CERE) | 2.5 | $165M | 5.1M | 32.42 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.3 | $147M | 5.2M | 28.41 | |
| Prometheus Biosciences | 1.9 | $126M | 3.2M | 39.54 | |
| Vbi Vaccines Inc Cda Com New | 1.9 | $123M | 52M | 2.34 | |
| Bridgebio Pharma (BBIO) | 1.8 | $119M | 7.1M | 16.68 | |
| Iveric Bio | 1.7 | $108M | 6.5M | 16.72 | |
| Rapt Therapeutics | 1.7 | $108M | 2.9M | 36.73 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $104M | 1.2M | 88.35 | |
| Nevro Corp Note 2.750% 4/0 (Principal) | 1.6 | $102M | 9.0M | 11.28 | |
| Global Blood Therapeutics In | 1.6 | $101M | 3.4M | 29.27 | |
| Coherus Biosciences (CHRS) | 1.3 | $86M | 5.4M | 15.96 | |
| Outset Med | 1.3 | $86M | 1.9M | 46.09 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $75M | 2.4M | 31.24 | |
| Landos Biopharma | 1.1 | $71M | 15M | 4.80 | |
| C4 Therapeutics Com Stk (CCCC) | 1.1 | $71M | 2.2M | 32.20 | |
| Apellis Pharmaceuticals (APLS) | 1.1 | $69M | 1.5M | 47.28 | |
| Bellus Health Com New | 1.0 | $62M | 7.6M | 8.05 | |
| Zymeworks | 0.9 | $60M | 3.7M | 16.39 | |
| Relay Therapeutics (RLAY) | 0.9 | $60M | 1.9M | 30.71 | |
| Inhibrx | 0.9 | $59M | 1.3M | 43.67 | |
| Travere Therapeutics (TVTX) | 0.9 | $57M | 1.8M | 31.04 | |
| Albireo Pharma | 0.8 | $55M | 2.4M | 23.29 | |
| Chemocentryx | 0.8 | $52M | 1.4M | 36.41 | |
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.8 | $52M | 4.5M | 11.44 | |
| Nautilus Biotechnology (NAUT) | 0.7 | $47M | 9.1M | 5.18 | |
| Arena Pharmaceuticals Com New | 0.7 | $47M | 500k | 92.94 | |
| Athira Pharma (ATHA) | 0.7 | $45M | 3.4M | 13.03 | |
| Kodiak Sciences (KOD) | 0.7 | $44M | 520k | 84.78 | |
| Icosavax | 0.7 | $44M | 1.9M | 22.88 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $43M | 2.0M | 21.83 | |
| Quotient SHS | 0.6 | $42M | 16M | 2.59 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $41M | 483k | 85.17 | |
| Morphic Hldg (MORF) | 0.6 | $40M | 837k | 47.38 | |
| Aldeyra Therapeutics (ALDX) | 0.6 | $40M | 9.9M | 4.00 | |
| Singular Genomics Systems In | 0.6 | $39M | 3.3M | 11.56 | |
| Isoplexis Corp | 0.6 | $38M | 4.1M | 9.19 | |
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $37M | 1.6M | 23.34 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.6 | $36M | 431k | 84.06 | |
| Immatics SHS (IMTX) | 0.5 | $34M | 2.5M | 13.44 | |
| Procept Biorobotics Corp (PRCT) | 0.5 | $33M | 1.3M | 25.01 | |
| Verrica Pharmaceuticals | 0.5 | $33M | 3.6M | 9.16 | |
| Kronos Bio | 0.5 | $33M | 2.4M | 13.59 | |
| Rain Therapeutics | 0.5 | $32M | 2.5M | 12.88 | |
| Tarsus Pharmaceuticals (TARS) | 0.5 | $29M | 1.3M | 22.50 | |
| Miragen Therapeutics (VRDN) | 0.4 | $28M | 1.4M | 19.77 | |
| Leap Therapeutics | 0.4 | $28M | 8.5M | 3.24 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $27M | 406k | 67.59 | |
| Cogent Biosciences (COGT) | 0.4 | $27M | 3.2M | 8.58 | |
| Caremax Com Cl A | 0.4 | $27M | 3.5M | 7.68 | |
| Macrogenics (MGNX) | 0.4 | $27M | 1.7M | 16.05 | |
| Female Health (VERU) | 0.4 | $26M | 4.5M | 5.89 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $25M | 2.9M | 8.50 | |
| Pulmonx Corp (LUNG) | 0.4 | $24M | 762k | 32.07 | |
| Invitae (NVTAQ) | 0.4 | $24M | 1.6M | 15.27 | |
| Solid Biosciences | 0.4 | $24M | 13M | 1.75 | |
| Pyxis Oncology Common Stock (PYXS) | 0.3 | $21M | 1.9M | 10.97 | |
| Cue Health (HLTHQ) | 0.3 | $21M | 1.6M | 13.41 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $20M | 94k | 216.08 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.3 | $19M | 2.9M | 6.72 | |
| Science 37 Holdings | 0.3 | $19M | 1.5M | 12.47 | |
| Athenex | 0.3 | $18M | 14M | 1.36 | |
| Treace Med Concepts (TMCI) | 0.3 | $18M | 980k | 18.64 | |
| Health Catalyst (HCAT) | 0.3 | $18M | 454k | 39.62 | |
| Dice Therapeutics | 0.3 | $18M | 705k | 25.31 | |
| Somalogic Class A Com | 0.3 | $18M | 1.5M | 11.64 | |
| Adma Biologics (ADMA) | 0.3 | $17M | 12M | 1.41 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $14M | 750k | 19.04 | |
| Lyra Therapeutics | 0.2 | $14M | 3.2M | 4.36 | |
| Viatris (VTRS) | 0.2 | $14M | 1.0M | 13.53 | |
| Cassava Sciences Put Option (SAVA) | 0.2 | $13M | 300k | 43.70 | |
| Bioatla (BCAB) | 0.2 | $13M | 661k | 19.63 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $12M | 360k | 34.24 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.2 | $12M | 1.0M | 11.98 | |
| Biogen Idec (BIIB) | 0.2 | $12M | 49k | 239.92 | |
| Absci Corp (ABSI) | 0.2 | $12M | 1.4M | 8.20 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $11M | 781k | 14.54 | |
| Sema4 Holdings Corp Com Cl A | 0.2 | $11M | 2.5M | 4.46 | |
| Merus N V (MRUS) | 0.2 | $11M | 350k | 31.80 | |
| Immuneering Corp Class A Com (IMRX) | 0.2 | $11M | 681k | 16.17 | |
| Hyperfine Com Cl A (HYPR) | 0.2 | $11M | 1.5M | 7.25 | |
| Graphite Bio | 0.2 | $11M | 850k | 12.43 | |
| Agile Therapeutics | 0.2 | $10M | 21M | 0.49 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.2 | $10M | 239k | 42.64 | |
| Summit Healthcre Acquistn Unit 06/03/2026 | 0.2 | $10M | 1.0M | 9.95 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $9.9M | 353k | 28.06 | |
| Kymera Therapeutics (KYMR) | 0.2 | $9.8M | 155k | 63.49 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $9.8M | 1.0M | 9.80 | |
| Research Alliance Corp Ii Com Cl A | 0.2 | $9.8M | 1.0M | 9.77 | |
| Tyra Biosciences (TYRA) | 0.1 | $9.5M | 673k | 14.07 | |
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $9.4M | 556k | 16.85 | |
| 1life Healthcare | 0.1 | $9.4M | 532k | 17.57 | |
| Celldex Therapeutics Com New (CLDX) | 0.1 | $8.9M | 230k | 38.64 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $8.8M | 189k | 46.61 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.1 | $8.6M | 1.1M | 8.10 | |
| Eqrx | 0.1 | $8.5M | 1.3M | 6.82 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $7.3M | 86k | 84.75 | |
| Astria Therapeutics (ATXS) | 0.1 | $6.9M | 1.3M | 5.39 | |
| Sight Sciences (SGHT) | 0.1 | $6.9M | 390k | 17.57 | |
| Concert Pharmaceuticals I equity | 0.1 | $6.8M | 2.2M | 3.15 | |
| Point Biopharma Global | 0.1 | $6.7M | 1.2M | 5.60 | |
| CryoLife (AORT) | 0.1 | $6.6M | 326k | 20.35 | |
| Accolade (ACCD) | 0.1 | $6.0M | 229k | 26.36 | |
| Clover Health Investments Com Cl A (CLOV) | 0.1 | $5.6M | 1.5M | 3.72 | |
| Provention Bio | 0.1 | $5.3M | 949k | 5.62 | |
| Oncorus | 0.1 | $5.3M | 1000k | 5.27 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $5.2M | 294k | 17.69 | |
| Envveno Medical (NVNO) | 0.1 | $5.1M | 782k | 6.59 | |
| Fusion Pharmaceuticals | 0.1 | $5.1M | 1.2M | 4.17 | |
| Prothena Corp SHS (PRTA) | 0.1 | $4.9M | 100k | 49.40 | |
| Da32 Life Scnce Tec Acqstn C Class A Com | 0.1 | $4.9M | 500k | 9.81 | |
| Codex Dna | 0.1 | $4.6M | 425k | 10.80 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.5M | 450k | 10.08 | |
| Dariohealth Corp Com New (DRIO) | 0.1 | $4.3M | 328k | 12.97 | |
| Neptune Wellness Solutions I | 0.1 | $4.1M | 10M | 0.41 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.1 | $4.1M | 386k | 10.64 | |
| Sonendo (SONX) | 0.1 | $3.9M | 669k | 5.76 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $3.8M | 755k | 5.01 | |
| Axsome Therapeutics (AXSM) | 0.0 | $3.0M | 80k | 37.78 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $2.9M | 125k | 23.10 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $2.8M | 422k | 6.75 | |
| Surrozen | 0.0 | $2.7M | 413k | 6.44 | |
| Vyne Therapeutics | 0.0 | $2.2M | 2.2M | 1.02 | |
| Deciphera Pharmaceuticals Call Option | 0.0 | $2.0M | 200k | 9.77 | |
| Nevro (NVRO) | 0.0 | $1.9M | 23k | 81.06 | |
| Ferrari Nv Ord (RACE) | 0.0 | $1.6M | 6.2k | 258.87 | |
| Iteos Therapeutics | 0.0 | $931k | 20k | 46.55 | |
| Motus Gi Hldgs Incorporated | 0.0 | $841k | 1.8M | 0.47 | |
| Eiger Biopharmaceuticals | 0.0 | $726k | 140k | 5.19 | |
| Rockley Photonics Holdings L *w Exp 08/11/202 | 0.0 | $605k | 500k | 1.21 | |
| Minerva Surgical | 0.0 | $451k | 88k | 5.14 | |
| Pharvaris N V (PHVS) | 0.0 | $389k | 27k | 14.41 | |
| Somalogic *w Exp 08/31/202 | 0.0 | $367k | 110k | 3.34 | |
| Butterfly Network *w Exp 02/12/202 (BFLY.WS) | 0.0 | $296k | 233k | 1.27 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $266k | 250k | 1.06 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $192k | 167k | 1.15 | |
| Caremax *w Exp 06/08/202 | 0.0 | $84k | 60k | 1.40 |